Nuvation Bio Inc.
NUVB · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $62.9M | $7.87M | +699% |
| Operating income | −$213M | −$593M | +64.0% |
| Net income | −$205M | −$568M | +64.0% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $45.0M | $13.1M | +244% |
| Operating income | −$42.2M | −$56.4M | +25.2% |
| Net income | −$41.9M | −$55.8M | +24.9% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Nuvation Bio's revenue in FY2025?
- $62.9M in FY2025 (Fiscal year ended Dec 31, 2025), +699% vs $7.87M a year earlier, per its 10-K filed Mar 2026.
- Was Nuvation Bio profitable in FY2025?
- No: net income was −$205M and operating income −$213M in FY2025.
- What was Nuvation Bio's revenue in Q3 2026?
- $45.0M (+244% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.